Suppr超能文献

原发性小梁切除术和莫尔顿植入物治疗原发性开角型青光眼的长期效果

Long-term results of primary trabeculectomies and Molteno implants for primary open-angle glaucoma.

作者信息

Molteno Anthony C B, Bevin Tui H, Herbison Peter, Husni Mohd Aziz

机构信息

Department of Medicine, University of Otago Dunedin School of Medicine, New Zealand.

出版信息

Arch Ophthalmol. 2011 Nov;129(11):1444-50. doi: 10.1001/archophthalmol.2011.221. Epub 2011 Jul 11.

Abstract

OBJECTIVE

To describe the long-term outcomes of primary trabeculectomies and primary Molteno implants performed in cases of primary open-angle glaucoma at Dunedin Hospital.

METHODS

Prospective comparative case series of 718 eyes (500 patients) and 260 eyes (195 patients) that had trabeculectomy and Molteno implants, respectively, at Dunedin Hospital as the first drainage operation for primary open-angle glaucoma between 1976 and 2007, and followed up for a mean of 7.7 (range, 0.0-28.0) and 5.0 (range, 0.0-27.4) years, respectively.

RESULTS

The probability of intraocular pressure (IOP) control at 21 mm Hg or less following trabeculectomy at 1, 2, 5, 10, 15, and 20 years was 0.95 (95% confidence interval [CI], 0.94-0.97), 0.93 (95% CI, 0.91-0.96), 0.89 (95% CI, 0.86-0.92), 0.82 (95% CI, 0.78-0.86), 0.74 (95% CI, 0.68-0.80), and 0.68 (95% CI, 0.59-0.77), respectively. There were 96 (13%) failures (using the >21-mm Hg definition of failure) in the trabeculectomy group by the final follow-up. The probability of IOP control at 21 mm Hg or less following Molteno implant insertion at 1, 2, 5, 10, 15, and 20 years was 0.98 (95% CI, 0.97-1.0), 0.97 (95% CI, 0.96-1.0), 0.96 (95% CI, 0.92-0.99), 0.96 (95% CI, 0.92-0.99), 0.91 (95% CI, 0.81-1.00), and 0.91 (95% CI, 0.81-1.00), respectively. In the Molteno implant group, there were 8 (3%) failures (using the >21-mm Hg definition of failure) by the final follow-up.

CONCLUSION

Insertion of a Molteno implant provided superior IOP control to trabeculectomy when carried out as a first operation in cases of primary glaucoma.

摘要

目的

描述在达尼丁医院对原发性开角型青光眼患者施行的原发性小梁切除术和原发性莫尔顿植入术的长期疗效。

方法

对1976年至2007年间在达尼丁医院分别接受小梁切除术和莫尔顿植入术作为原发性开角型青光眼首次引流手术的718只眼(500例患者)和260只眼(195例患者)进行前瞻性比较病例系列研究,平均随访时间分别为7.7年(范围0.0 - 28.0年)和5.0年(范围0.0 - 27.4年)。

结果

小梁切除术后1年、2年、5年、10年、15年和20年眼压控制在21 mmHg或更低的概率分别为0.95(95%置信区间[CI],0.94 - 0.97)、0.93(95% CI,0.91 - 0.96)、0.89(95% CI,0.86 - 0.92)、0.82(95% CI,0.78 - 0.86)、0.74(95% CI,0.68 - 0.80)和0.68(95% CI,0.59 - 0.77)。到最终随访时,小梁切除术组有96例(13%)失败(采用眼压>21 mmHg的失败定义)。莫尔顿植入术后1年、2年、5年、10年、15年和20年眼压控制在21 mmHg或更低的概率分别为0.98(95% CI,0.97 - 1.0)、0.97(95% CI,0.96 - 1.0)、0.96(95% CI,0.92 - 0.99)、0.96(95% CI,0.92 - 0.99)、0.91(95% CI,0.81 - 1.00)和0.91(95% CI,0.81 - 1.00)。到最终随访时,莫尔顿植入术组有8例(3%)失败(采用眼压>21 mmHg的失败定义)。

结论

在原发性青光眼病例中,作为首次手术,莫尔顿植入术在眼压控制方面优于小梁切除术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验